作者: Andrey V. Cybulsky , Julie Guillemette , Joan Papillon , Nihad T. Abouelazm
DOI: 10.1371/JOURNAL.PONE.0177226
关键词:
摘要: … Erlotinib was originally developed as an inhibitor of the epidermal growth factor (EGF) … activity of SLK (and the related lymphocyte-oriented kinase), and to be an effective SLK inhibitor […